# Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents

> **NCT01609998** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 75 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Seasonal Influenza DNA vaccine
- **BIOLOGICAL:** TIV

## Key facts

- **NCT ID:** NCT01609998
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2018-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01609998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01609998, "Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01609998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*